Literature DB >> 1864986

Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

A J Simpson1, N A Booth, N R Moore, B Bennett.   

Abstract

Extracts of human tissue were analysed for plasminogen activator inhibitor (PAI-1) antigen and activity. PAI-1 was localised in tissues by an immunochemical method, using monoclonal antibodies. PAI-1 occurred throughout the body; its concentration and activity differed considerably from organ to organ. Extracts of liver and spleen had the greatest abundance of PAI-1, but the activity of the inhibitor was much higher in liver than in spleen: the liver may be a source of plasma PAI-1. Immunochemical staining for PAI-1 was observed in endothelium, platelets and their precursor cells, the megakaryocytes, and locations central to the process of haemostasis. PAI-1 also occurred in neutrophil polymorphs and macrophages, cells important in inflammatory and immune processes, but not in lymphocytes. Other cell types, in particular, vascular smooth muscle cells and mesangial cells, also stained positively for PAI-1 and such cells seem to represent an important reservoir of PAI-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864986      PMCID: PMC496976          DOI: 10.1136/jcp.44.2.139

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.

Authors:  J Chmielewska; B Wiman
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

2.  Platelet release protein which inhibits plasminogen activators.

Authors:  N A Booth; J A Anderson; B Bennett
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

3.  The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease.

Authors:  A J Simpson; N A Booth; N R Moore; B Bennett
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

4.  Plasminogen activator inhibitor (PAI-1) in plasma and platelets.

Authors:  N A Booth; A J Simpson; A Croll; B Bennett; I R MacGregor
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

5.  Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.

Authors:  I Juhan-Vague; B Moerman; F De Cock; M F Aillaud; D Collen
Journal:  Thromb Res       Date:  1984-03-01       Impact factor: 3.944

6.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

Authors:  E K Kruithof; C Tran-Thang; A Ransijn; F Bachmann
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

7.  Human glomerular smooth muscle (mesangial) cells in culture.

Authors:  J I Scheinman; A J Fish; D M Brown; A J Michael
Journal:  Lab Invest       Date:  1976-02       Impact factor: 5.662

8.  Characterization of a plasminogen activator and its inhibitor in human mesangial cells.

Authors:  R Lacave; E Rondeau; S Ochi; F Delarue; W D Schleuning; J D Sraer
Journal:  Kidney Int       Date:  1989-03       Impact factor: 10.612

9.  The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Authors:  C Kluft; J H Verheijen; A F Jie; D C Rijken; F E Preston; H M Sue-Ling; J Jespersen; A O Aasen
Journal:  Scand J Clin Lab Invest       Date:  1985-11       Impact factor: 1.713

10.  An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1).

Authors:  I R MacGregor; N A Booth
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

View more
  27 in total

1.  Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).

Authors:  Nitin Patel; Nambirajan Sundaram; Mingyan Yang; Catherine Madigan; Vijay K Kalra; Punam Malik
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

2.  Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis.

Authors:  M Bonyadi; Z Shaghaghi; M Haghi; S Dastgiri
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

3.  Different Effects of Lipopolysaccharide on Plasminogen Activator Inhibitor-1 Production in Aortic Media in Vivo and in Culture.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

4.  Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.

Authors:  P Fitch; B Bennett; N A Booth; A Croll; S W Ewen
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).

Authors:  Benjamin R Huebner; Ernest E Moore; Hunter B Moore; Gregory R Stettler; Geoffrey R Nunns; Peter Lawson; Angela Sauaia; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2018-12       Impact factor: 3.454

6.  Biochemical dynamics relevant to the safety of low-dose, intraclot alteplase for deep vein thrombosis.

Authors:  Jay N Lozier; Ann M Cullinane; Khanh Nghiem; Richard Chang; McDonald K Horne
Journal:  Transl Res       Date:  2012-02-23       Impact factor: 7.012

7.  Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

Authors:  F O Akenami; M Koskiniemi; M Färkkilä; A Vaheri
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

8.  Obesity and clotting: Body mass index independently contributes to hypercoagulability after injury.

Authors:  Lucy Z Kornblith; Benjamin Howard; Ryan Kunitake; Brittney Redick; Mary Nelson; Mitchell Jay Cohen; Rachael Callcut
Journal:  J Trauma Acute Care Surg       Date:  2015-01       Impact factor: 3.313

9.  Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction.

Authors:  K Yorimitsu; T Saito; T Toyozaki; T Ishide; N Ohnuma; Y Inagaki
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

10.  Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

Authors:  P Eriksson; B Kallin; F M van 't Hooft; P Båvenholm; A Hamsten
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.